Yan Zhao

Title: Innovations in Pharmaceutical Technology by Yan Zhao

Introduction

Yan Zhao is a notable inventor based in Anhui, China, recognized for his contributions to pharmaceutical technology. With a focus on developing innovative treatments for skin inflammatory diseases, Zhao has secured 2 patents that highlight his expertise in medicinal chemistry.

Latest Patents

Zhao's latest patents include a compound pharmaceutical composition for treating skin inflammatory diseases. This innovative composition combines tofacitinib and crisaborole, resulting in a stronger therapeutic effect and lower dosage, showcasing a significant synergistic therapeutic effect. The pharmaceutical composition is designed to effectively treat various skin inflammatory conditions. Another notable patent involves a compound that inhibits phosphodiesterase 4 (PDE-4). This small molecule compound, along with its preparation method and pharmaceutical applications, demonstrates promising inhibitory activity against the PDE-4 enzyme, proving effective in inflammation treatment.

Career Highlights

Throughout his career, Yan Zhao has worked with prominent companies in the pharmaceutical industry, including Hefei Industrial Pharmaceutical Institute Co., Ltd and Hefei Amvite Pharmaceutical Co., Ltd. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Zhao has collaborated with various professionals in the field, including his coworker Zhaoxing Chu, who has also made significant contributions to pharmaceutical innovations.

Conclusion

Yan Zhao's innovative work in pharmaceutical technology, particularly in developing treatments for skin inflammatory diseases, underscores his role as a leading inventor in the field. His patents reflect a commitment to enhancing therapeutic options and improving patient outcomes.